[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351096-105":59,"doc-detail-351096-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","fanconi-anemia-complementation-group-c-gene-fancc-association-with-hereditary-and-sporadic-renal-tumors","Fanconi anemia complementation group C gene (FANCC) association with hereditary and sporadic renal tumors","","Background: Inactivating genomic alterations of the FANCC gene drive genomic instability, DNA cross-linking, and homologous DNA repair deficiency. This study assessed how often FANCC genomic alterations occur across renal tumors and described key associated biomarkers. Methods: Hybrid-capture comprehensive genomic profiling of clinically advanced cancer cases used the FDA-approved F1CDx assay to detect diverse alteration classes and evaluate MSI, TMB, loss of heterozygosity, germline prediction, and genomic signature. Results and conclusions are summarized with low incidence but a substantial germline-predicted proportion in FANCC-mutated renal tumors, supporting germline testing.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/fanconi-anemia-complementation-group-c-gene-fancc-association-with-hereditary-and-sporadic-renal-tumors/351096/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/fanconi-anemia-complementation-group-c-gene-fancc-association-with-hereditary-and-sporadic-renal-tumors/351096.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role does FANCC genomic alteration play in tumor biology?","Question",{"text":113,"@type":114},"Inactivating FANCC genomic alterations are linked to genomic instability, DNA cross-linking, and homologous DNA repair deficiency, which can contribute to cancer development.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How frequently were FANCC alterations found in renal tumors in this study?",{"text":118,"@type":114},"Among clinically advanced renal tumors, FANCC alterations were present in a very small subset, with 27 FANCC-mutated tumors identified out of 7668 renal tumors analyzed.",{"name":120,"@type":111,"acceptedAnswer":121},"Why does the study recommend germline testing for FANCC-mutated renal tumors?",{"text":122,"@type":114},"A high proportion of FANCC-mutated renal tumors were predicted to carry germline FANCC mutations, indicating that inherited variants may be common and warrant genetic evaluation.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351096,1790172868,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":46,"preview_page_count":19,"preview_urls":145},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Fanconi anemia complementation group C gene (FANCC) association with hereditary and sporadic renal tumors  \nDevashish Desai, MBBS1, *,, Rebecca A. Sager2, *, Michael Basin, MD2, Joseph M. Jacob, MD, MCR2, Gloria Joan Morris, MD, PhD1, Philippe E. Spiess, MD3, Roger Li4, Liang Cheng5, Andrea Necchi6,, Ashish M. Kamat, MBBS, FACS7, Petros Grivas, MD, PhD8, Dean Pavlick9, Hanan Goldberg, MD2, Mehdi Mollapour, MD, PhD2, Douglas Lin9, Jeffrey S. Ross, MD2,9, Gennady Bratslavsky, MD2, Alina Basnet, MD1, Michael A. Daneshvar, MD10  \n1Division of Hematology and Oncology, Department of Hematology and Medical Oncology, SUNY Upstate Medical University, Syracuse, NY, USA  \n2Department of Urology, SUNY Upstate Medical University, Syracuse, NY, USA  \n3Department of Urology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA 4Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA 5Department of Pathology, Warren Alpert Medical School of Brown University, Providence, RI, USA 6Vita-Salute San Raffaele University, Milan, Italy  \n7The University of Texas MD Anderson Cancer Center, Houton, TX, USA  \n8Department of Medicine, Division of Hematology/Oncology, University of Washington, Fred Hutchinson Cancer Center, Seattle, WA, USA 9Foundation Medicine, Inc, Cambridge, MA, USA  \n10Department of Urology, University of California, Irvine Health, Orange, CA, USA  \n*Corresponding author: Devashish Desai, MBBS, Department of Hematology Oncology, SUNY Upstate Medical University, Syracuse, NY, USA ([devashishdesai25@gmail.com](devashishdesai25@gmail.com)) .  \nAbstract  \nBackground: Inactivating genomic alterations (GA) of the FANCC gene are associated with genomic instability, DNA cross-linking, and homologous DNA repair deficiency. Here, we evaluated the incidence of FANCC GA in renal tumors (RT) .  \nMethods: A total of 463 546 clinically advanced cancer (CAC) cases underwent hybrid capture-based comprehensive genomic profiling using the FDA-approved F1CDx assay to detect all classes of GA. Microsatellite instability (MSI) status, tumor mutational burden (TMB), genomic loss of heterozygosity, prediction of germline status, and genomic signature were determined with algorithm-based analysis.  \nResults: Clinically advanced cancers (0 .43% of 1993) featured FANCC GA; 27 of these FANCC-mutated tumors (20 males, mean age 57) were RT (0 .35% of 7668 RT) . The primary tumor was sequenced in 9 cases and a metastatic site in 18 (5 lymph nodes, 4 soft tissues, 3 brains, 2 livers, 1 each lung, adrenal, eye, bone) . Only 1 of 25 tested FANCC-mutated RT was MSI-high; 4 cases (15%) featured TMB ≥10 mutations/Mb. The genomic signature could be assessed in 5 cases: 4 were MMR-deficient. The FANCC mutations included inactivating short variant mutations in 24 cases (10 nonsense, 10 frameshift, 2 non-frame, and 2 splice-site mutations) and 3 truncating rearrangements (FANCC: SUSD3, FANCC: FANCC, and FANCC: C20orf24) . Interestingly, 14 (52%) of the FANCC-mutated RT were predicted to be germline.  \nConclusions: Somatic and germline mutations in FANCC occur in an exceedingly small subset of clinically advanced RT but at a similar rate to other cancers, and the genomic landscape does not appear to be different from RT with wild-type FANCC. Germline testing is warranted, as we see a high frequency of germline FANCC mutations.  \nPatient Summary: Our study highlights the rate of FANCC mutation in kidney cancer, which may be a therapeutic target and awaits further assessment and drug development. Also, it shows that FANCC mutations are more germline, requiring further genetic testing.  \nKey words: kidney cancer, FANCC, hereditary kidney cancer, comprehensive genomic profiling.  \nImplications for Practice  \nThe current trend in further utilization of next-generation sequencing to analyze the tumor genetics and its application in finding targets for newer therapies has led us to do a study on highlighting the incide","cbCaibkFf7H1zwgy","https://ap.wps.com/l/cbCaibkFf7H1zwgy","pdf",4602709,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Implications for Practice\n# Patient Summary\n# Key words\n# Received and Accepted","[{\"question\":\"What role does FANCC genomic alteration play in tumor biology?\",\"answer\":\"Inactivating FANCC genomic alterations are linked to genomic instability, DNA cross-linking, and homologous DNA repair deficiency, which can contribute to cancer development.\"},{\"question\":\"How frequently were FANCC alterations found in renal tumors in this study?\",\"answer\":\"Among clinically advanced renal tumors, FANCC alterations were present in a very small subset, with 27 FANCC-mutated tumors identified out of 7668 renal tumors analyzed.\"},{\"question\":\"Why does the study recommend germline testing for FANCC-mutated renal tumors?\",\"answer\":\"A high proportion of FANCC-mutated renal tumors were predicted to carry germline FANCC mutations, indicating that inherited variants may be common and warrant genetic evaluation.\"}]","Fanconi anemia complementation group C gene (FANCC) association with hereditary and sporadic renal tumors | PDF",1790092603,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36a197497af6886044217bca465f0472.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5701d932186c222d5dd9692f8dd85d2.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bcdb2ee6e6d605c3f7f28a4f4ab7c979.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1843b099329e43010adde1ad188ea37a.webp",980,1287]